How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,113 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Mechanical Diagnosis and Therapy vs Traditional Physical Therapy in the Treatment of Mechanical Headaches

of treatment. The MDT method focuses on actively involving the patient in education and self-management of pain. The focus is to have the patient learn about his/her condition and how to manage the symptoms independently when possible. With regards to research that has been conducted on the use of MDT with headaches, one study compared mechanical traction, rhythmic impulse, and MDT exercises in relieving tension-type headaches (TTH). Mechanical cervical traction was found to be more effective at reducing (...) % of adults worldwide, and the pain can have a detrimental effect on an individual's livelihood. In a two-week time period, 12.7% of the US workforce was unable to productively work due to pain, with headache pain as the most common complaint. For those with headache pain, this resulted in 3.5 +/- 0.1 hours of productivity lost in a week. Quality of life, financial situation, employment, and social involvement are negatively impacted by headache pain. Coworkers and family may have to handle work

2017 Clinical Trials

82. Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics

: Washington University School of Medicine Information provided by (Responsible Party): Washington University School of Medicine Study Details Study Description Go to Brief Summary: During labor and delivery, pregnant women may choose to receive pain relief called epidural analgesia, which is the delivery of a numbing agent through the back and into a body space around the spinal column. This numbs the area of the stomach and the pelvis. Typically the numbing agent is lidocaine, which is a local anesthetic (...) like your dentist uses. Some times the numbing agent is combined with another medication that causes drowsiness and relieves pain called a narcotic. One of the risks associated with having this kind of pain relief is unintentional puncture of a sheath of tissue that surrounds and protects the spinal cord when inserting the needle. This sheath is called the dura. This would cause the fluid surrounding the spinal cord to leak out and this would cause a headache. This headache is called a post-dural

2017 Clinical Trials

83. Intravenous Fluids in Benign Headaches Trail

and availability for benign headaches is prochlorperazine. Given that IVF administration is a common part of treatment regimen for benign headache patients in the emergency department and given the lack of randomized trials in adults, the investigators aim to study the use of IVF on pain reduction in headache patients in the adult ED. There has been one randomized trial in pediatrics that shows IVF may help in patients with migraines, whereas the adult literature has no randomized control trials and a review (...) of data shows that fluids do not help relieve pain in migraine headache patients. This study will include both adult and pediatric patients presenting to the Emergency Department with complaint of benign headache. Condition or disease Intervention/treatment Phase Headache Drug: Normal Saline 5mL Drug: Normal Saline 20mL/kg Drug: Prochlorperazine 0.15 mg/kg up to 10 mg IV Drug: Diphenhydramine 1 mg/kg up to 50 mg IV Phase 4 Detailed Description: This will be a single center, prospective, single blinded

2017 Clinical Trials

84. Yoga for Pediatric Tension-Type Headache

for Headache Disorders criteria, be between 13 and 18 years old (inclusive), English-speaking, and willing to be randomized and attend yoga sessions regularly. Exclusion Criteria: Participants will be excluded if they have any injury, disease, or metabolic dysfunction known to influence pain, have any physical limitations deemed by a medical practitioner to preclude yoga practice, had attended yoga classes in the previous 3 months, are currently pregnant, or have a history of drug or alcohol dependence (...) Study Details Study Description Go to Brief Summary: This study will determine the efficacy of an 8-week Hatha yoga intervention for adolescents with tension-type headache (TTH) and will assess theoretically-driven mediators of treatment response, including experimental pain sensitivity, chronic stress, and negative cognitions linked to chronic pain. Condition or disease Intervention/treatment Phase Headache Behavioral: Hatha yoga Not Applicable Study Design Go to Layout table for study information

2017 Clinical Trials

85. Headache Inducing Effect of Cromakalim in Migraine Patients

Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations Signs and Symptoms Cromakalim Antihypertensive Agents Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Asthmatic Agents Respiratory System Agents Parasympatholytics Vasodilator Agents (...) Headache Inducing Effect of Cromakalim in Migraine Patients Headache Inducing Effect of Cromakalim in Migraine Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Headache Inducing Effect of Cromakalim

2017 Clinical Trials

86. EFFECTS OF MIOFASCIAL RELEASE AND PERCUTANEOUS MICROELETROLYSIS IN TYPE HEADACHE

, 2017 Last Update Posted : July 21, 2017 See Sponsor: Rodrigo Marcel Valentim da Silva Information provided by (Responsible Party): Rodrigo Marcel Valentim da Silva, Estácio Ponta Negra Study Details Study Description Go to Brief Summary: A headache is a more common disorder and one that prevails over a lifetime of much of the population. Among the causes are in the stress and spasms of the pericranial musculature, presence of painful sensitivity in the region, decrease of pain threshold (...) : Layout table for MeSH terms Headache Tension-Type Headache Pain Neurologic Manifestations Signs and Symptoms Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases

2017 Clinical Trials

87. Ketamine v. Ketorolac for Management of Generalized Tension Type Headache

, confusion, agitation, delirium, dreams) during study period, incidence of nausea, vomiting, or worsening headache, Incidence of bad taste, Incidence of burning sensations in the nostrils, incidence of hypertension, time to patient discharge from the initiation of study medication/placebo, patient satisfaction of pain control based on a Likert Scale. Condition or disease Intervention/treatment Phase Migraine Drug: Intravenous ketamine Drug: Ketorolac Drug: Normal saline Phase 4 Detailed Description (...) of the following no nausea/vomiting No more than one of photophobia or phonophobia Exclusion Criteria: Non migraine primary headache disorder or unclassifiable, previous enrollment in study, fever >100.3, Patients with suspected secondary headache disorder such as SAH or sinusitis, performance of lumbar puncture or potential need for LP, Severe hypertension (≥180/100), History of CAD or hypertension, presence of/suspected for traumatic head injury in the past 30 days with or without loss of consciousness

2017 Clinical Trials

88. Treatment of Chronic Migraine Headaches.

to any components of De-Novo formula Presence or known anatomic craniofacial deformities or severe spondylosis/spondylolisthesis of cervical spine, profound dental caries, Maxillofacial deformities Pregnancy and current breast feeding status Headaches attribute to acute head and neck injuries, chronicity of cervicogenic headaches Skin infection or micro abscesses dermatogen or dental, ongoing treatment for Methicillin Resistant Streptococcus Aureus ( MRSA) unless treatment completed. Contacts (...) .: Migraine Craniofacial Neuralgia Additional relevant MeSH terms: Layout table for MeSH terms Migraine Disorders Headache Migraine without Aura Migraine with Aura Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations Signs and Symptoms Dexamethasone Dexamethasone acetate Lidocaine BB 1101 Thiamine Anti-Inflammatory Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects

2017 Clinical Trials

89. Pregnancy and Renal Disease

to the survey, including 76 (49%) nephrologists, 36 (23%) obstetricians, 16 (10%) pharmacists, 12 (8%) midwives, 7 (4%) obstetric physicians, 5 (3%) physicians, 2 (1%) patients, 1 dietician and 1 person with role in guideline development. Of those completing the survey, 57 (37%) were part of a specialist multidisciplinary team managing women with CKD in pregnancy and 72 (46%) were routinely involved in either the renal or obstetric care of pregnant women with CKD. The strength of the recommendation (...) guidelines 19 6. Lay summary 74 7. Acknowledgements 75 Appendix 1. The experience of pregnancy and renal disease……………………………………………………………………………….76 Appendix 2. Summary of clinical responsibility for elements of the guideline 80 Appendix 3. Ovid Medline search terms (1946 to 2018) 81 Renal Association Clinical Practice Guideline Pregnancy and Renal Disease – September 2019 4 1. Introduction 1. Background Chronic kidney disease (CKD) is estimated to affect 3% of pregnant women in high-income countries

2019 Renal Association

90. CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients

: Layout table for MeSH terms Headache Cluster Headache Pain Neurologic Manifestations Signs and Symptoms Trigeminal Autonomic Cephalalgias Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Calcitonin Salmon calcitonin Katacalcin Calcitonin Gene-Related Peptide Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Bone Density Conservation Agents Vasodilator Agents (...) in remission minimum of 1 month remission time fertile women must use safe contraception Exclusion Criteria: All other primary types of headache headache 8 hours or less before study day begins pregnant or lactating women any history or clinical sigs of hyper/hypotension, heart disease, mental disorder, substance abuse, or other illness deemed relevant by the medical doctor assessing the patient Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study

2015 Clinical Trials

91. Acute headache diagnosis in pregnant women: A hospital-based study. Full Text available with Trip Pro

Acute headache diagnosis in pregnant women: A hospital-based study. To characterize demographic and clinical features in pregnant women presenting with acute headache, and to identify clinical features associated with secondary headache.We conducted a 5-year, single-center, retrospective study of consecutive pregnant women presenting to acute care with headache receiving neurologic consultation.The 140 women had a mean age of 29 ± 6.4 years and often presented in the third trimester (56.4 (...) ), fever (8.2% vs 0.0%, p = 0.014), and an abnormal neurologic examination (34.7% vs 16.5%, p = 0.014). In multivariate logistic regression, elevated blood pressure (odds ratio [OR] 17.0, 95% confidence interval [CI] 4.2-56.0) and a lack of headache history (OR 4.9, 95% CI 1.7-14.5) had an increased association with secondary headache, while psychiatric comorbidity (OR 0.13, 95% CI 0.021-0.78) and phonophobia (OR 0.29, 95% CI 0.09-0.91) had a reduced association with secondary headache.Among pregnant

2015 Neurology

92. Overview of pregnancy complications

Obstet Gynecol. 2000;183:S1-S22. http://www.ncbi.nlm.nih.gov/pubmed/10920346?tool=bestpractice.com Pre-eclampsia is usually asymptomatic but may present with headache, seizure, blurred vision, and abdominal pain. Risk factors include nulliparity (or first pregnancy with new partner), family history of pre-eclampsia, body mass index >30, maternal age >35 years, and multiple (twin) pregnancy. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension (...) Overview of pregnancy complications Overview of pregnancy complications - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of pregnancy complications Last reviewed: February 2019 Last updated: September 2018 Introduction Complications in pregnancy can result from conditions that are specifically linked to the pregnant state as well as conditions that commonly arise or occur incidentally in women who are pregnant

2018 BMJ Best Practice

93. Molar pregnancies

). Gestational trophoblastic disease includes tumours of fetal tissues, including hydatidiform moles, arising from placental trophoblasts. Syncytiotrophoblasts secrete human chorionic gonadotrophin and, therefore, this hormonal product is used as a tumour marker for the disease. History and exam presence of risk factors first trimester of pregnancy missed period vaginal bleeding unusually large uterus for gestational age headache and photophobia shortness of breath and respiratory distress severe nausea (...) Molar pregnancies Molar pregnancies - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Molar pregnancies Last reviewed: February 2019 Last updated: March 2018 Summary Chromosomally abnormal pregnancies that have the potential to become malignant. Higher possibility of gestational trophoblastic disease (GTD) for women less than 20 years of age or over 35 years of age, and in those who have experienced GTD in a previous

2018 BMJ Best Practice

94. Nausea and vomiting in pregnancy

Nausea and vomiting in pregnancy Nausea and vomiting in pregnancy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Nausea and vomiting in pregnancy Last reviewed: February 2019 Last updated: March 2018 Summary Affects approximately 75% of pregnant women. Typically begins between the fourth and seventh week after the last menstrual period and resolves in the second trimester. Aetiology remains unclear. There is some (...) trophoblastic disease other causes of increased placental mass female fetus history of motion sickness history of migraine headache Diagnostic investigations full blood count basic metabolic panel serum liver function tests serum urea and creatinine serum thyroid-stimulating hormone (TSH) and free T4 urinalysis urine or serum ketones fetal ultrasound with nuchal translucency serum analytes Helicobacter pylori breath test urine culture serum amylase and lipase RUQ ultrasound renal ultrasound cranial CT

2018 BMJ Best Practice

95. Overview of pregnancy complications

Obstet Gynecol. 2000;183:S1-S22. http://www.ncbi.nlm.nih.gov/pubmed/10920346?tool=bestpractice.com Pre-eclampsia is usually asymptomatic but may present with headache, seizure, blurred vision, and abdominal pain. Risk factors include nulliparity (or first pregnancy with new partner), family history of pre-eclampsia, body mass index >30, maternal age >35 years, and multiple (twin) pregnancy. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension (...) Overview of pregnancy complications Overview of pregnancy complications - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of pregnancy complications Last reviewed: February 2019 Last updated: September 2018 Introduction Complications in pregnancy can result from conditions that are specifically linked to the pregnant state as well as conditions that commonly arise or occur incidentally in women who are pregnant

2018 BMJ Best Practice

96. Assessment of abdominal pain in pregnancy

Assessment of abdominal pain in pregnancy Assessment of abdominal pain in pregnancy - Differential diagnosis of symptoms | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Assessment of abdominal pain in pregnancy Last reviewed: February 2019 Last updated: June 2018 Summary Abdominal pain throughout pregnancy is common. Many adaptive or physiological changes of pregnancy affect the presentation. Women tend to visit doctors often as they are concerned (...) about the health of their fetus. Patients require a careful assessment in order to reduce anxiety and give reassurance. If the clinical picture is unclear, a specialist should be consulted. Chamberlain G. ABC of antenatal care: abdominal pain in pregnancy. BMJ. 1991;302:390-1394. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1670063/pdf/bmj00129-0073.pdf http://www.ncbi.nlm.nih.gov/pubmed/2059722?tool=bestpractice.com Augustin G, Majerovic M. Non-obstetrical acute abdomen during pregnancy. Eur J

2018 BMJ Best Practice

97. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Full Text available with Trip Pro

with obesity or who are overweight, acting to reduce glucose production in the liver and improve glucose uptake in smooth muscle cells, and therefore improve the overall metabolic health of women in pregnancy and reduce the risk of known adverse pregnancy outcomes.To evaluate the role of metformin in pregnant women with obesity or who are overweight, on maternal and infant outcomes, including adverse effects of treatment and costs.We searched Cochrane Pregnancy and Childbirth's Trials Register (...) ; 2 studies, 840 women; low-quality evidence). Metformin probably makes little or no difference in the risk of women developing gestational diabetes (RR 0.85, 95% CI 0.61 to 1.19; 3 studies, 892 women; moderate-quality evidence).One study of 400 women reported women receiving metformin were more likely to experience any adverse effect compared with women receiving placebo (RR 1.63, 95% CI 1.27 to 2.08; 1 study, 400 women). Adverse effects included abdominal pain, diarrhoea, or headache. When

2018 Cochrane

98. Management of Cardiovascular Diseases during Pregnancy Full Text available with Trip Pro

dissection, and myocardial infarction (MI) were the most common causes of maternal death in the UK over the period 2006–08. Knowledge of the risks associated with CVDs during pregnancy and their management in pregnant women who suffer from serious pre-existing conditions is of pivotal importance for advising patients before pregnancy. Since all measures concern not only the mother but the foetus as well, the optimum treatment of both must be targeted. A therapy favourable for the mother can be associated (...) Management of Cardiovascular Diseases during Pregnancy We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close

2018 European Society of Cardiology

99. PRAC recommends new measures to avoid valproate exposure in pregnancy

, with the details to be adapted at national level. A patient reminder card will also be attached to the outer package for pharmacists to discuss with the patient each time the medicine is dispensed. Companies that market valproate should also provide updated educational materials in the form of guides for healthcare professionals and patients. What are the main points of the new valproate pregnancy prevention programme? Assessing patients for the potential of becoming pregnant, and involving the patient (...) PRAC recommends new measures to avoid valproate exposure in pregnancy PRAC recommends new measures to avoid valproate exposure in pregnancy | European Medicines Agency Search Search Menu PRAC recommends new measures to avoid valproate exposure in pregnancy Press release 09/02/2018 New restrictions on use; pregnancy prevention programme to be put in place The European Medicines Agency's experts in medicines safety, the ( ) are recommending new measures to avoid exposure of babies to valproate

2018 European Medicines Agency - EPARs

100. Treating Opioid Use Disorder During Pregnancy: Guideline Supplement

of Family Medicine, St. Joseph’s Health Center, Toronto Launette Rieb, MD, MSc, CCFP , FCFP , Dip. ABAM, CCSAM; Medical Consultant, St Paul’s Hospital; Physician, Orchard Recovery Centre; Physician, Orion Health (Vancouver Pain Clinic); Clinical Associate Professor, University of British Columbia 6 Acknowledgements The Pregnancy Supplement Development Committee would like to thank Dr. Peter Blanken, Dr. Scott MacDonald, Dr. Hans-Guenter Meyer-Thompson, and Dr. Marc Vogel for their expert guidance (...) represent the view of the Pregnancy Supplement Committee, arrived at after careful consideration of the available scientific evidence and external expert peer review. When treating pregnant patients with opioid use disorder, health care professionals are expected to consider this guideline supplement alongside the recommendations articulated in A Guideline for the Clinical Management of Opioid Use Disorder. These guidelines should be considered and interpreted in the context of the individual needs

2018 British Columbia Perinatal Health Program

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>